FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Giorgio Scalise

Research Profile

Procedures

Chemicals & Drugs

Living Beings

Disorders

Physiology

Drug Synergism

Co-author Network

Publications

TOP 3
Andrea Giacometti; Luca Butini; Oscar Cirioni; Andrea Costantini; Maria Montroni; Giorgio Scalise
[Durability and tolerability of long-term nevirapine-based HAART].
Oriana Simonetti; G Ganzetti; Daniela Arzeni; Anna Campanati; B Marconi; Carmela Silvestri; Oscar Cirioni; E Gabrielli; I Lenci; Wojciech Kamysz; Elzbieta Kamysz; Andrea Giacometti; Giorgio Scalise; Francesco Barchiesi; Annamaria Offidani
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
Elisabetta Spreghini; Fiorenza Orlando; Alfredo Santinelli; Eleonora Pisa; Cristian Loretelli; Esther Manso; Maria E Milici; Giorgio Scalise; Francesco Barchiesi
Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Giorgio Scalise (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Andrea Giacometti; Luca Butini; Oscar Cirioni; Andrea Costantini; Maria Montroni; Giorgio Scalise
[Durability and tolerability of long-term nevirapine-based HAART].
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 2010;18(1):20-6.
2009: Oriana Simonetti; G Ganzetti; Daniela Arzeni; Anna Campanati; B Marconi; Carmela Silvestri; Oscar Cirioni; E Gabrielli; I Lenci; Wojciech Kamysz; Elzbieta Kamysz; Andrea Giacometti; Giorgio Scalise; Francesco Barchiesi; Annamaria Offidani
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
Peptides 2009;30(10):1794-7.
2009: Elisabetta Spreghini; Fiorenza Orlando; Alfredo Santinelli; Eleonora Pisa; Cristian Loretelli; Esther Manso; Maria E Milici; Giorgio Scalise; Francesco Barchiesi
Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2009;53(9):4035-9.
2009: Francesco Barchiesi; Carmela Silvestri; Daniela Arzeni; Giulia Ganzetti; Sefora Castelletti; Oriana Simonetti; Oscar Cirioni; Wojciech Kamysz; Elzbieta Kamysz; Elisabetta Spreghini; Alessandra Abruzzetti; Alessandra Riva; Annamaria Offidani; Andrea Giacometti; Giorgio Scalise
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47(3):321-6.
2009: Oscar Cirioni; Carmela Silvestri; Roberto Ghiselli; Fiorenza Orlando; Alessandra Riva; Eleonora Gabrielli; Federico Mocchegiani; Nancy Cianforlini; Maria Michela Cappelletti Trombettoni; Vittorio Saba; Giorgio Scalise; Andrea Giacometti
Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.
Critical care medicine 2009;37(4):1403-7.
2008: Carmelo Massimo Maida; Maria E Milici; Laura Trovato; Salvatore Oliveri; Emanuele Amodio; Elisabetta Spreghini; Giorgio Scalise; Francesco Barchiesi
Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.
Journal of clinical microbiology 2008;46(12):4071-4.
2008: Oscar Cirioni; Carmela Silvestri; Roberto Ghiselli; Fiorenza Orlando; Alessandra Riva; Federico Mocchegiani; Leonardo Chiodi; Sefora Castelletti; Eleonora Gabrielli; Vittorio Saba; Giorgio Scalise; Andrea Giacometti
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
The Journal of antimicrobial chemotherapy 2008;62(6):1332-8.
2008: Oscar Cirioni; Roberto Ghiselli; Carmela Silvestri; Wojciech Kamysz; Fiorenza Orlando; Alessandra Riva; Elzbieta Kamysz; Sefora Castelletti; Marco Rocchi; Vittorio Saba; Giorgio Scalise; Andrea Giacometti
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.
Antimicrobial agents and chemotherapy 2008;52(12):4351-5.
2008: Oscar Cirioni; Roberto Ghiselli; Linda Tomasinsig; Fiorenza Orlando; Carmela Silvestri; Barbara Skerlavaj; Alessandra Riva; Marco Rocchi; Vittorio Saba; Margherita Zanetti; Giorgio Scalise; Andrea Giacometti
Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.
Shock (Augusta, Ga.) 2008;30(4):443-8.
2008: Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Carmela Silvestri; Stefania De Luca; Anna Maria Salzano; Federico Mocchegiani; Vittorio Saba; Giorgio Scalise; Andrea Scaloni; Andrea Giacometti
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
Critical care medicine 2008;36(9):2629-33.
2008: Mauro Dalla Serra; Oscar Cirioni; Rosa Maria Vitale; Giovanni Renzone; Manuela Coraiola; Andrea Giacometti; Cristina Potrich; Elisa Baroni; Graziano Guella; Marina Sanseverino; Stefania De Luca; Giorgio Scalise; Pietro Amodeo; Andrea Scaloni
Structural features of distinctin affecting peptide biological and biochemical properties.
Biochemistry 2008;47(30):7888-99.
2008: Fiorenza Orlando; Roberto Ghiselli; Oscar Cirioni; Daniele Minardi; Linda Tomasinsig; Federico Mocchegiani; Carmela Silvestri; Barbara Skerlavaj; Alessandra Riva; Giovanni Muzzonigro; Vittorio Saba; Giorgio Scalise; Margherita Zanetti; Andrea Giacometti
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
Peptides 2008;29(7):1118-23.
2008: Oriana Simonetti; Oscar Cirioni; Roberto Ghiselli; Gaia Goteri; alessandro scalise; Fiorenza Orlando; Carmela Silvestri; Alessandra Riva; Vittorio Saba; Kiran D Madanahally; Annamaria Offidani; Naomi Balaban; Giorgio Scalise; Andrea Giacometti
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2008;52(6):2205-11.
2008: Elisabetta Spreghini; Carmelo Massimo Maida; Serena Tomassetti; Fiorenza Orlando; Daniele Giannini; Maria E Milici; Giorgio Scalise; Francesco Barchiesi
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Antimicrobial agents and chemotherapy 2008;52(6):1929-33.
2008: Oriana Simonetti; Oscar Cirioni; Gaia Goteri; Roberto Ghiselli; Wojciech Kamysz; Elzbieta Kamysz; Carmela Silvestri; Fiorenza Orlando; Claudia Barucca; alessandro scalise; Vittorio Saba; Giorgio Scalise; Andrea Giacometti; Annamaria Offidani
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model.
Peptides 2008;29(4):520-8.
2008: Elisabetta Spreghini; Carmelo Massimo Maida; Maria E Milici; Giorgio Scalise; Francesco Barchiesi
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Antimicrobial agents and chemotherapy 2008;52(2):513-7.
2008: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Federico Mocchegiani; Fiorenza Orlando; Carmela Silvestri; Fabio Di Matteo; Alessandra Abbruzzetti; Giorgio Scalise; Vittorio Saba
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Critical care medicine 2008;36(1):240-5.
2008: Oscar Cirioni; Roberto Ghiselli; Wojciech Kamysz; Fiorenza Orlando; Carmela Silvestri; Federico Mocchegiani; Fabio Di Matteo; Elzbieta Kamysz; Alessandra Riva; Marco Rocchi; Vittorio Saba; Giorgio Scalise; Andrea Giacometti
Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
Peptides 2008;29(1):31-8.
2008: Roberto Ghiselli; Oscar Cirioni; Andrea Giacometti; alessandro scalise; Oriana Simonetti; Federico Mocchegiani; Fiorenza Orlando; Gaia Goteri; Agnese Della Vittoria; Alessandra Filosa; Carmela Silvestri; Annamaria Offidani; Aldo Bertani; Giorgio Scalise; Vittorio Saba
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections.
The Journal of surgical research 2008;144(1):74-81.
2007: Daniele Minardi; Roberto Ghiselli; Oscar Cirioni; Andrea Giacometti; Wojciech Kamysz; Fiorenza Orlando; Carmela Silvestri; Gianni Parri; Elzbieta Kamysz; Giorgio Scalise; Vittorio Saba; Muzzonigro Giovanni
The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model.
Peptides 2007;28(12):2293-8.
2007: Oscar Cirioni; Roberto Ghiselli; Daniele Minardi; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Giovanni Muzzonigro; Vittorio Saba; Giorgio Scalise; Naomi Balaban; Andrea Giacometti
RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.
Antimicrobial agents and chemotherapy 2007;51(12):4518-20.
2007: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Federico Mocchegiani; Carmela Silvestri; Fiorenza Orlando; Wojciech Kamysz; Alberto Licci; Piotr Nadolski; Agnese Della Vittoria; Jerzy Łukasiak; Giorgio Scalise; Vittorio Saba
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.
JPEN. Journal of parenteral and enteral nutrition 2007;31(6):463-8.
2007: Maria E Milici; Carmelo Massimo Maida; Elisabetta Spreghini; Barbara Ravazzolo; Salvatore Oliveri; Giorgio Scalise; Francesco Barchiesi
Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.
Journal of clinical microbiology 2007;45(11):3529-33.
2007: Francesco Barchiesi; Andrea Giacometti; Oscar Cirioni; Daniela Arzeni; Wojciech Kamysz; Carmela Silvestri; Alberto Licci; Anna Marigliano; Agnese Della Vittoria; Piotr Nadolski; J Łukasiak; Giorgio Scalise
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp.
Journal of chemotherapy (Florence, Italy) 2007;19(5):514-8.
2007: Francesco Barchiesi; Andrea Giacometti; Oscar Cirioni; Daniela Arzeni; Carmela Silvestri; Wojciech Kamysz; Alessandra Abbruzzetti; Alessandra Riva; Elzbieta Kamysz; Giorgio Scalise
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.
Peptides 2007;28(8):1509-13.
2007: Katia Marinelli; Patrizia Bagnarelli; Gianni Gaffi; Silvia Trappolini; Pietro Leoni; Aldo Paggi; Agnese Della Vittoria; Giorgio Scalise; Pietro E Varaldo; Stefano Menzo
PCR real time assays for the early detection of BKV-DNA in immunocompromised patients.
The new microbiologica 2007;30(3):275-8.
2007: Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Carmela Silvestri; Federico Mocchegiani; Marco Rocchi; Leonardo Chiodi; Alessandra Abbruzzetti; Vittorio Saba; Giorgio Scalise; Andrea Giacometti
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
Critical care medicine 2007;35(7):1717-23.
2007: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Wojciech Kamysz; Carmela Silvestri; Fiorenza Orlando; Federico Mocchegiani; Agnese Della Vittoria; Elzbieta Kamysz; Vittorio Saba; Giorgio Scalise
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
Peptides 2007;28(6):1299-303.
2007: Oscar Cirioni; Andrea Giacometti; Wojciech Kamysz; Carmela Silvestri; Alessandra Riva; Agnese Della Vittoria; Alessandra Abbruzzetti; Jerzy Lukasiak; Giorgio Scalise
In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
Peptides 2007;28(4):747-51.
2007: Andrea Giacometti; Oscar Cirioni; Alessandra Riva; Wojciech Kamysz; Carmela Silvestri; Piotr Nadolski; Agnese Della Vittoria; Jerzy Łukasiak; Giorgio Scalise
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
Antimicrobial agents and chemotherapy 2007;51(4):1494-6.
2007: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Carmela Silvestri; Giovanni Renzone; Irma Testa; Federico Mocchegiani; Agnese Della Vittoria; Vittorio Saba; Andrea Scaloni; Giorgio Scalise
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection.
Journal of biomedical materials research. Part A 2007;81(1):233-9.
2007: Francesco Barchiesi; Elisabetta Spreghini; Serena Tomassetti; Daniele Giannini; Giorgio Scalise
Caspofungin in combination with amphotericin B against Candida parapsilosis.
Antimicrobial agents and chemotherapy 2007;51(3):941-5.
2007: Francesco Barchiesi; Daniela Arzeni; G Greganti; Anna Marigliano; Serena Tomassetti; Elisabetta Spreghini; Giorgio Scalise
Fluconazole susceptibility of Candida spp. isolates collected over nine years in a teaching hospital of Ancona, Italy.
Journal of chemotherapy (Florence, Italy) 2007;19(1):58-61.
2007: Wojciech Kamysz; Carmela Silvestri; Oscar Cirioni; Andrea Giacometti; Alberto Licci; Agnese Della Vittoria; Marcin Okroj; Giorgio Scalise
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci.
Antimicrobial agents and chemotherapy 2007;51(1):354-8.
2007: Francesco Barchiesi; Elisabetta Spreghini; Alfredo Santinelli; Annette W Fothergill; Eleonora Pisa; Daniele Giannini; Michael G Rinaldi; Giorgio Scalise
Posaconazole prophylaxis in experimental systemic zygomycosis.
Antimicrobial agents and chemotherapy 2007;51(1):73-7.
2006: Oscar Cirioni; Andrea Giacometti; Carmela Silvestri; Agnese Della Vittoria; Alberto Licci; Alessandra Riva; Giorgio Scalise
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 2006;50(11):3923-5.
2006: Roberto Ghiselli; Oscar Cirioni; Andrea Giacometti; Federico Mocchegiani; Fiorenza Orlando; Cristina Bergnach; Barbara Skerlavaj; Carmela Silvestri; Agnese Della Vittoria; Margherita Zanetti; Marco Rocchi; Giorgio Scalise; Vittorio Saba
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide.
Peptides 2006;27(11):2592-9.
2006: Oscar Cirioni; Carmela Silvestri; Roberto Ghiselli; Andrea Giacometti; Fiorenza Orlando; Federico Mocchegiani; Leonardo Chiodi; Agnese Della Vittoria; Vittorio Saba; Giorgio Scalise
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.
Peptides 2006;27(11):2600-6.
2006: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Giorgio Dell'Acqua; Cristina Bergnach; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Barbara Skerlavaj; Alberto Licci; Naomi Balaban; Margherita Zanetti; Giorgio Scalise; Vittorio Saba
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Shock (Augusta, Ga.) 2006;26(3):296-301.
2006: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Carmela Silvestri; Fiorenza Orlando; Wojciech Kamysz; Alberto Licci; Elzbieta Kamysz; Jerzy Lukasiak; Vittorio Saba; Giorgio Scalise
Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats.
Critical care medicine 2006;34(9):2415-20.
2006: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Cristina Bergnach; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Alberto Licci; Barbara Skerlavaj; Margherita Zanetti; Vittorio Saba; Giorgio Scalise
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection.
Peptides 2006;27(9):2104-10.
2006: Roberto Ghiselli; Oscar Cirioni; Andrea Giacometti; Federico Mocchegiani; Fiorenza Orlando; Carmela Silvestri; Alberto Licci; Agnese Della Vittoria; Giorgio Scalise; Vittorio Saba
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock.
Shock (Augusta, Ga.) 2006;26(2):195-200.
2006: Francesco Barchiesi; Elisabetta Spreghini; Serena Tomassetti; Agnese Della Vittoria; Daniela Arzeni; Esther Manso; Giorgio Scalise
Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
Antimicrobial agents and chemotherapy 2006;50(8):2719-27.
2006: Corrado Girmenia; Giampaolo Pizzarelli; Francesco Cristini; Francesco Barchiesi; Elisabetta Spreghini; Giorgio Scalise; Pietro Martino
Candida guilliermondii fungemia in patients with hematologic malignancies.
Journal of clinical microbiology 2006;44(7):2458-64.
2006: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Fiorenza Orlando; Carmela Silvestri; Argante Bozzi; Antonio Di Giulio; Carla Luzi; Maria Luisa Mangoni; Donatella Barra; Vittorio Saba; Giorgio Scalise; Andrea C Rinaldi
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Antimicrobial agents and chemotherapy 2006;50(7):2478-86.
2006: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Wojciech Kamysz; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Alberto Licci; Leonardo Chiodi; Jerzy Lukasiak; Vittorio Saba; Giorgio Scalise
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Peptides 2006;27(6):1210-6.
2006: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Cristina Bergnach; Fiorenza Orlando; Carmela Silvestri; Federico Mocchegiani; Alberto Licci; Barbara Skerlavaj; Marco Rocchi; Vittorio Saba; Margherita Zanetti; Giorgio Scalise
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
Antimicrobial agents and chemotherapy 2006;50(5):1672-9.
2006: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Giorgio Dell'Acqua; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Alberto Licci; Vittorio Saba; Giorgio Scalise; Naomi Balaban
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
The Journal of infectious diseases 2006;193(2):180-6.
2006: Wojciech Kamysz; Piotr Nadolski; Anna Kedzia; Oscar Cirioni; Francesco Barchiesi; Andrea Giacometti; Giorgio Scalise; Jerzy Lukasiak; Marcin Okrój
In vitro activity of synthetic antimicrobial peptides against Candida.
Polish journal of microbiology / Polskie Towarzystwo Mikrobiologów = The Polish Society of Microbiologists 2006;55(4):303-7.
2005: Francesco Barchiesi; Elisabetta Spreghini; Alfredo Santinelli; Annette W Fothergill; Stefania Fallani; Esther Manso; Eleonora Pisa; Daniele Giannini; Andrea Novelli; Maria Iris Cassetta; Teresita Mazzei; Michael G Rinaldi; Giorgio Scalise
Efficacy of caspofungin against Aspergillus terreus.
Antimicrobial agents and chemotherapy 2005;49(12):5133-5.
2005: Francesco Barchiesi; Elisabetta Spreghini; Serena Tomassetti; Daniela Arzeni; Daniele Giannini; Giorgio Scalise
Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
Antimicrobial agents and chemotherapy 2005;49(12):4989-92.
2005: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Carmela Silvestri; Alberto Licci; Alessandra Riva; Jerzy Łukasiak; Giorgio Scalise
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
Peptides 2005;26(11):2111-6.
2005: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Wojciech Kamysz; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Alberto Licci; Jerzy Łukasiak; Vittorio Saba; Giorgio Scalise
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
The Journal of infectious diseases 2005;192(9):1613-20.
2005: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Alberto Licci; Matteo De Fusco; Mauro Provinciali; Vittorio Saba; Giorgio Scalise
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2005;49(10):4042-5.
2005: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Carmela Silvestri; Alberto Licci; Giuseppina D'Amato; Piotr Nadolski; Alessandra Riva; Jerzy Lukasiak; Giorgio Scalise
In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.
Antimicrobial agents and chemotherapy 2005;49(9):3933-6.
2005: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Giuseppina D'Amato; Carmela Silvestri; Alberto Licci; Piotr Nadolski; Alessandra Riva; Jerzy Lukasiak; Giorgio Scalise
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
International journal of antimicrobial agents 2005;26(3):235-40.
2005: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Carmela Silvestri; Maria Simona Del Prete; Alberto Licci; Giuseppina D'Amato; Jerzy Lukasiak; Giorgio Scalise
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
The Journal of antimicrobial chemotherapy 2005;56(2):410-2.
2005: Francesco Barchiesi; Massimo Cogliati; Maria Carmela Esposto; Elisabetta Spreghini; Anna M Schimizzi; Brian L Wickes; Giorgio Scalise; Maria Anna Viviani
Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis.
The Journal of infection 2005;51(1):10-6.
2005: Francesco Barchiesi; Elisabetta Spreghini; Annette W Fothergill; Daniela Arzeni; Gianfranco Greganti; Daniele Giannini; Michael G Rinaldi; Giorgio Scalise
Caspofungin in combination with amphotericin B against Candida glabrata.
Antimicrobial agents and chemotherapy 2005;49(6):2546-9.
2005: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Carmela Silvestri; Maria Simona Del Prete; Alberto Licci; Giuseppina D'Amato; Jerzy Łukasiak; Giorgio Scalise
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections.
Antimicrobial agents and chemotherapy 2005;49(6):2507-9.
2005: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Giuseppina D'Amato; Carmela Silvestri; Maria Simona Del Prete; Alberto Licci; Alessandra Riva; Jerzy Lukasiak; Giorgio Scalise
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.
Antimicrobial agents and chemotherapy 2005;49(3):1249-52.
2005: Francesco Barchiesi; Anna Maria Tortorano; L Falconi Di Francesco; Anna Lisa Rigoni; Andrea Giacometti; Elisabetta Spreghini; Giorgio Scalise; Maria Anna Viviani
Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates.
Journal of medical microbiology 2005;54(Pt 3):279-85.
2005: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Giuseppina D'Amato; Carmela Silvestri; Maria Simona Del Prete; Alberto Licci; Jerzy Lukasiak; Giorgio Scalise
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.
The Journal of antimicrobial chemotherapy 2005;55(2):272-4.
2005: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Wojciech Kamysz; Marco Rocchi; Giuseppina D'Amato; Federico Mocchegiani; Carmela Silvestri; Jerzy Łukasiak; Vittorio Saba; Giorgio Scalise
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
Peptides 2005;26(2):207-16.
2005: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Giorgio Dell'Acqua; Fiorenza Orlando; Giuseppina D'Amato; Federico Mocchegiani; Carmela Silvestri; Maria Simona Del Prete; Marco Rocchi; Naomi Balaban; Vittorio Saba; Giorgio Scalise
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Peptides 2005;26(2):169-75.
2004: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Cristina Bergnach; Fiorenza Orlando; Giuseppina D'Amato; Federico Mocchegiani; Carmela Silvestri; Maria Simona Del Prete; Barbara Skerlavaj; Vittorio Saba; Margherita Zanetti; Giorgio Scalise
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Critical care medicine 2004;32(12):2485-90.
2004: Francesco Barchiesi; Monia Maracci; Isabella Baldassarri; Elisabetta Spreghini; Daniele Giannini; Giorgio Scalise
Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
Diagnostic microbiology and infectious disease 2004;50(3):179-85.
2004: Francesco Barchiesi; Elisabetta Spreghini; Isabella Baldassarri; Anna Marigliano; Daniela Arzeni; Daniele Giannini; Giorgio Scalise
Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Antimicrobial agents and chemotherapy 2004;48(10):4056-8.
2004: Francesco Barchiesi; Elisabetta Spreghini; Monia Maracci; Annette W Fothergill; Isabella Baldassarri; Michael G Rinaldi; Giorgio Scalise
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Antimicrobial agents and chemotherapy 2004;48(9):3317-22.
2004: Francesco Barchiesi; Elisabetta Spreghini; Anna M Schimizzi; Monia Maracci; Daniele Giannini; Flavia Carle; Giorgio Scalise
Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
Antimicrobial agents and chemotherapy 2004;48(9):3312-6.
2004: Andrea Giacometti; Roberto Ghiselli; Oscar Cirioni; Federico Mocchegiani; Giuseppina D'Amato; Fiorenza Orlando; Valerio Sisti; Wojciech Kamysz; Carmela Silvestri; Piotr Naldoski; Jerzy Lukasiak; Vittorio Saba; Giorgio Scalise
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
The Journal of antimicrobial chemotherapy 2004;54(3):654-60.
2004: Francesco Barchiesi; Giuseppina Caggiano; L Falconi Di Francesco; Maria Teresa Montagna; Salvatore Barbuti; Giorgio Scalise
Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit.
Diagnostic microbiology and infectious disease 2004;49(4):269-71.
2004: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Giuseppina D'Amato; Wojciech Kamysz; Federico Mocchegiani; Valerio Sisti; Carmela Silvestri; Jerzy Łukasiak; Marco Rocchi; Vittorio Saba; Giorgio Scalise
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Antimicrobial agents and chemotherapy 2004;48(8):3162-4.
2004: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Fiorenza Orlando; Wojciech Kamysz; Giuseppina D'Amato; Federico Mocchegiani; Jerzy Lukasiak; Carmela Silvestri; Vittorio Saba; Giorgio Scalise
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
The Journal of infectious diseases 2004;190(2):356-64.
2004: Giorgio Dell'Acqua; Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Vittorio Saba; Giorgio Scalise; Yael Gov; Naomi Balaban
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
The Journal of infectious diseases 2004;190(2):318-20.
2004: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Giuseppina D'Amato; Carmela Silvestri; Maria Simona Del Prete; Jerzy Lukasiak; Giorgio Scalise
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
Diagnostic microbiology and infectious disease 2004;49(3):197-200.
2004: Naomi Balaban; Yael Gov; Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Fiorenza Orlando; Giuseppina D'Amato; Vittorio Saba; Giorgio Scalise; Sabina Bernes; Amram Mor
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci.
Antimicrobial agents and chemotherapy 2004;48(7):2544-50.
2004: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Giorgio Dell'Acqua; Federico Mocchegiani; Fiorenza Orlando; Giuseppina D'Amato; Marco Rocchi; Giorgio Scalise; Vittorio Saba
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2004;27(6):603-7.
2004: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Federico Mocchegiani; Fiorenza Orlando; Giuseppina D'Amato; Valerio Sisti; Giorgio Scalise; Vittorio Saba
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
Annals of surgery 2004;239(2):251-6.
2004: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Giuseppina D'Amato; Raffaella Circo; Fiorenza Orlando; Barbara Skerlavaj; Carmela Silvestri; Vittorio Saba; Margherita Zanetti; Giorgio Scalise
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.
American journal of respiratory and critical care medicine 2004;169(2):187-94.
2003: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Claudio Viticchi; Fiorenza Orlando; Giuseppina D'Amato; Maria Simona Del Prete; Wojciech Kamysz; Jerzy łLukasiak; Vittorio Saba; Giorgio Scalise
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock.
Peptides 2003;24(11):1747-52.
2003: Andrea Giacometti; Roberto Ghiselli; Oscar Cirioni; Federico Mocchegiani; Fiorenza Orlando; Maria Simona Del Prete; Giuseppina D'Amato; Carmela Silvestri; Vittorio Saba; Giorgio Scalise
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
The Journal of antimicrobial chemotherapy 2003;52(4):724-6.
2003: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Giuseppina D'Amato; Carmela Silvestri; Maria Simona Del Prete; Jerzy Łukasiak; Giorgio Scalise
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Peptides 2003;24(9):1315-8.
2003: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Giorgio Dell'Acqua; Yael Gov; Wojciech Kamysz; Jerzy Lukasiak; Federico Mocchegiani; Fiorenza Orlando; Giuseppina D'Amato; Naomi Balaban; Vittorio Saba; Giorgio Scalise
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Circulation 2003;108(6):767-71.
2003: Andrea Giacometti; Oscar Cirioni; Leonardo Antonicelli; Giuseppina D'Amato; Carmela Silvestri; Maria Simona Del Prete; Giorgio Scalise
Prevalence of intestinal parasites among individuals with allergic skin diseases.
The Journal of parasitology 2003;89(3):490-2.
2003: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Raffaella Circo; Federico Mocchegiani; Barbara Skerlavaj; Giuseppina D'Amato; Giorgio Scalise; Margherita Zanetti; Vittorio Saba
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide.
Shock (Augusta, Ga.) 2003;19(6):577-81.
2003: Andrea Giacometti; Oscar Cirioni; Yael Gov; Roberto Ghiselli; Maria Simona Del Prete; Federico Mocchegiani; Vittorio Saba; Fiorenza Orlando; Giorgio Scalise; Naomi Balaban; Giorgio Dell'Acqua
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2003;47(6):1979-83.
2003: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; G D'Amato; Maria Simona Del Prete; Fiorenza Orlando; Wojciech Kamysz; Jerzy Lukasiak; Vittorio Saba; Giorgio Scalise
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.
Gut 2003;52(6):874-8.
2003: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Federico Mocchegiani; Giuseppina D'Amato; Carmela Silvestri; Alessandra Riva; Maria Simona Del Prete; Vittorio Saba; Giorgio Scalise
Antiendotoxin activity of antimicrobial peptides and glycopeptides.
Journal of chemotherapy (Florence, Italy) 2003;15(2):129-33.
2003: Andrea Giacometti; Oscar Cirioni; Maria Simona Del Prete; Barbara Skerlavaj; Raffaella Circo; Margherita Zanetti; Giorgio Scalise
In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides.
The Journal of antimicrobial chemotherapy 2003;51(4):843-7.
2003: Naomi Balaban; Andrea Giacometti; Oscar Cirioni; Yael Gov; Roberto Ghiselli; Federico Mocchegiani; Claudio Viticchi; Maria Simona Del Prete; Vittorio Saba; Giorgio Scalise; Giorgio Dell'Acqua
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
The Journal of infectious diseases 2003;187(4):625-30.
2003: Francesco Barchiesi; Giuseppina Caggiano; Monia Maracci; Daniela Arzeni; Giorgio Scalise; Maria Teresa Montagna
Antifungal susceptibility patterns of yeast isolates causing bloodstream infections.
The Journal of antimicrobial chemotherapy 2003;51(2):431-3.
2003: Francesco Barchiesi; Maria E Milici; Daniela Arzeni; Anna M Schimizzi; Giuseppe Pizzo; Giovanni M Giammanco; Daniele Giannini; Marco Manfrini; Giorgio Scalise; Chiara B Vicentini
In vitro and in vivo anticryptococcal activities of a new pyrazolo-isothiazole derivative.
The Journal of antimicrobial chemotherapy 2003;51(1):167-70.
2002: Francesco Barchiesi; Monia Maracci; Brunella Radi; Daniela Arzeni; Isabella Baldassarri; Andrea Giacometti; Giorgio Scalise
Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy.
The Journal of antimicrobial chemotherapy 2002;50(6):999-1002.
2002: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Federico Mocchegiani; Claudio Viticchi; Giorgio Scalise; Vittorio Saba
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model.
The Journal of surgical research 2002;108(1):107-11.
2002: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Federico Mocchegiani; Fiorenza Orlando; Wojciech Kamysz; Maria Simona Del Prete; Jerzy Lukasiak; Giorgio Scalise; Vittorio Saba
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.
Journal of vascular surgery 2002;36(5):1027-30.
2002: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Federico Mocchegiani; Fiorenza Orlando; Maria Simona Del Prete; G D'Amato; Giorgio Scalise; Vittorio Saba
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2002;24(3):230-4.
2002: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Federico Mocchegiani; Alessandra Riva; Maria Simona Del Prete; Vittorio Saba; Giorgio Scalise
Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Antimicrobial agents and chemotherapy 2002;46(9):2885-8.
2002: Andrea Giacometti; Oscar Cirioni; G Greganti; Anna Fineo; Roberto Ghiselli; Maria Simona Del Prete; Federico Mocchegiani; B Fileni; F Caselli; E Petrelli; Vittorio Saba; Giorgio Scalise
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(7):553-6.
2002: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Maria Simona Del Prete; Claudio Viticchi; Wojciech Kamysz; Elzbieta ŁEmpicka; Vittorio Saba; Giorgio Scalise
Potential therapeutic role of cationic peptides in three experimental models of septic shock.
Antimicrobial agents and chemotherapy 2002;46(7):2132-6.
2002: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Franciszek Kasprzykowski; Francesco Barchiesi; Maria Simona Del Prete; Zbigniew Maćkiewicz; Giorgio Scalise
In vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity.
Peptides 2002;23(5):1015-8.
2002: Giuseppe Pizzo; Francesco Barchiesi; L Falconi Di Francesco; Giovanna Giuliana; Daniela Arzeni; Maria E Milici; Matteo D'Angelo; Giorgio Scalise
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.
Archives of oral biology 2002;47(3):189-96.
2002: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Aldo Paggi; Fiorenza Orlando; Wojciech Kamysz; Franciszek Kasprzykowski; Zbigniew Mackiewicz; Giorgio Scalise; Vittorio Saba
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock.
The Journal of antimicrobial chemotherapy 2002;49(1):193-6.
2002: Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Federico Mocchegiani; Anna Fineo; Fiorenza Orlando; Maria Simona Del Prete; Marco Rocchi; Vittorio Saba; Giorgio Scalise
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model.
Antimicrobial agents and chemotherapy 2002;46(1):101-4.
2001: Francesco Barchiesi; Anna M Schimizzi; F Caselli; Daniele Giannini; V Camiletti; B Fileni; Andrea Giacometti; L Falconi Di Francesco; Giorgio Scalise
Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 2001;48(6):769-73.
2001: Francesco Barchiesi; Daniela Arzeni; V Camiletti; Oriana Simonetti; Andreina Cellini; Annamaria Offidani; Giorgio Scalise
In vitro activity of posaconazole against clinical isolates of dermatophytes.
Journal of clinical microbiology 2001;39(11):4208-9.
2001: Roberto Ghiselli; Andrea Giacometti; Oscar Cirioni; Fiorenza Orlando; Federico Mocchegiani; A M Pacci; Giorgio Scalise; Vittorio Saba
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.
The Journal of surgical research 2001;100(2):183-8.
2001: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Claudio Viticchi; Federico Mocchegiani; Alessandra Riva; Vittorio Saba; Giorgio Scalise
Effect of mono-dose intraperitoneal cecropins in experimental septic shock.
Critical care medicine 2001;29(9):1666-9.
2001: Roberto Ghiselli; Andrea Giacometti; L Goffi; Oscar Cirioni; Federico Mocchegiani; Fiorenza Orlando; Aldo Paggi; E Petrelli; Giorgio Scalise; Vittorio Saba
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
The Journal of surgical research 2001;99(2):316-20.
2001: Francesco Barchiesi; Anna M Schimizzi; Laura K Najvar; Rosie Bocanegra; F Caselli; S Di Cesare; Daniele Giannini; L Falconi Di Francesco; Andrea Giacometti; Flavia Carle; Giorgio Scalise; John Graybill
Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2001;45(5):1355-9.
2001: Andrea Giacometti; O Cirioni; R Ghiselli; F Mocchegiani; A Riva; V Saba; Giorgio Scalise
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 2001;9(1):13-8.
2001: Francesco Barchiesi; L Falconi Di Francesco; Daniela Arzeni; F Caselli; Oriana Simonetti; Andreina Cellini; Andrea Giacometti; Annamaria Offidani; Giorgio Scalise
Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections.
Mycopathologia 2001;149(3):117-21.
2001: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Anna Fineo; Giorgio Scalise
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture.
The Journal of antimicrobial chemotherapy 2001;47(1):97-9.
2000: Roberto Ghiselli; Andrea Giacometti; L Goffi; Oscar Cirioni; Gianfranco Boccoli; Federico Mocchegiani; Alessandra Riva; Giorgio Scalise; Vittorio Saba
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2000;20(6):508-11.
2000: Andrea Giacometti; Oscar Cirioni; Maria Simona Del Prete; Francesco Barchiesi; Giorgio Scalise
Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture.
Antimicrobial agents and chemotherapy 2000;44(12):3473-5.
2000: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; L Goffi; Federico Mocchegiani; Alessandra Riva; Giorgio Scalise; Vittorio Saba
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
Antimicrobial agents and chemotherapy 2000;44(12):3306-9.
2000: Andrea Giacometti; Oscar Cirioni; Maria Simona Del Prete; Francesco Barchiesi; Aldo Paggi; E Petrelli; Giorgio Scalise
Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
The Journal of antimicrobial chemotherapy 2000;46(5):807-10.
2000: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; L Goffi; Federico Mocchegiani; Alessandra Riva; Giorgio Scalise; Vittorio Saba
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis.
The Journal of antimicrobial chemotherapy 2000;46(5):751-6.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Giorgio Scalise
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Diagnostic microbiology and infectious disease 2000;38(2):115-8.
2000: Oscar Cirioni; Andrea Giacometti; Francesco Barchiesi; Giorgio Scalise
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline.
The Journal of antimicrobial chemotherapy 2000;46(4):577-82.
2000: Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; L Goffi; Claudio Viticchi; Federico Mocchegiani; Alessandra Riva; Fiorenza Orlando; Vittorio Saba; Giorgio Scalise
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.
Antimicrobial agents and chemotherapy 2000;44(10):2842-4.
2000: Francesco Barchiesi; Anna M Schimizzi; F Caselli; Andrea Novelli; Stefania Fallani; Daniele Giannini; Daniela Arzeni; S Di Cesare; L Falconi Di Francesco; M Fortuna; Andrea Giacometti; Flavia Carle; Teresita Mazzei; Giorgio Scalise
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2000;44(9):2435-41.
2000: Andrea Giacometti; Oscar Cirioni; Maria Simona Del Prete; Aldo Paggi; MM D'Errico; Giorgio Scalise
Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria.
Peptides 2000;21(8):1155-60.
2000: Andrea Giacometti; Oscar Cirioni; Maria Simona Del Prete; Francesco Barchiesi; M Fortuna; D Drenaggi; Giorgio Scalise
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.
Antimicrobial agents and chemotherapy 2000;44(6):1716-9.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Maria Simona Del Prete; M Fortuna; F Caselli; Giorgio Scalise
In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically.
Antimicrobial agents and chemotherapy 2000;44(6):1694-6.
2000: Francesco Barchiesi; D Calabrese; Dominique Sanglard; L Falconi Di Francesco; F Caselli; Daniele Giannini; Andrea Giacometti; S Gavaudan; Giorgio Scalise
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750.
Antimicrobial agents and chemotherapy 2000;44(6):1578-84.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; F Ancarani; Giorgio Scalise
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems.
The Journal of antimicrobial chemotherapy 2000;45(5):651-4.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; F Ancarani; Giorgio Scalise
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.
The Journal of antimicrobial chemotherapy 2000;45(4):453-6.
2000: Francesco Barchiesi; Daniela Arzeni; F Caselli; Giorgio Scalise
Primary resistance to flucytosine among clinical isolates of Candida spp.
The Journal of antimicrobial chemotherapy 2000;45(3):408-9.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Giorgio Scalise
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines.
The Journal of antimicrobial chemotherapy 2000;45(3):375-7.
2000: Andrea Giacometti; Oscar Cirioni; Anna M Schimizzi; Maria Simona Del Prete; Francesco Barchiesi; MM D'Errico; E Petrelli; Giorgio Scalise
Epidemiology and microbiology of surgical wound infections.
Journal of clinical microbiology 2000;38(2):918-22.
2000: Andrea Giacometti; Oscar Cirioni; M Fortuna; P Osimani; L Antonicelli; Maria Simona Del Prete; A Riva; MM D'Errico; E Petrelli; Giorgio Scalise
Environmental and serological evidence for the presence of toxocariasis in the urban area of Ancona, Italy.
European journal of epidemiology 2000;16(11):1023-6.
2000: L Lamura; Ruth C Matthews; Francesco Barchiesi; M Donahoe; James Burnie; Giorgio Scalise
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.
The Journal of infection 2000;40(1):64-8.
2000: Francesco Barchiesi; Daniela Arzeni; Annette W Fothergill; L Falconi Di Francesco; F Caselli; Michael G Rinaldi; Giorgio Scalise
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens.
Antimicrobial agents and chemotherapy 2000;44(1):226-9.
1999: Andrea Giacometti; F Burzacchini; Oscar Cirioni; Francesco Barchiesi; M Dini; Giorgio Scalise
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(12):885-9.
1999: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; M Fortuna; Giorgio Scalise
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(11):827-9.
1999: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Maria Simona Del Prete; Giorgio Scalise
Antimicrobial activity of polycationic peptides.
Peptides 1999;20(11):1265-73.
1999: Oscar Cirioni; Andrea Giacometti; Francesco Barchiesi; M Fortuna; Giorgio Scalise
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1999;44(5):653-9.
1999: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; M Fortuna; Giorgio Scalise
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 1999;44(5):641-5.
1999: L Falconi Di Francesco; Francesco Barchiesi; F Caselli; Oscar Cirioni; Giorgio Scalise
Comparison of four methods for DNA typing of clinical isolates of Candida glabrata.
Journal of medical microbiology 1999;48(10):955-63.
1999: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; F Caselli; Giorgio Scalise
In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates.
The Journal of antimicrobial chemotherapy 1999;44(3):403-6.
1999: Andrea Giacometti; Oscar Cirioni; F Ancarani; Maria Simona Del Prete; M Fortuna; Giorgio Scalise
In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Antimicrobial agents and chemotherapy 1999;43(8):2093-6.
1999: Francesco Barchiesi; D Gallo; F Caselli; L Falconi Di Francesco; Daniela Arzeni; Andrea Giacometti; Giorgio Scalise
In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 1999;44(1):65-70.
1999: Andrea Giacometti; Oscar Cirioni; A Fiorentini; M Fortuna; Giorgio Scalise
Irritable bowel syndrome in patients with Blastocystis hominis infection.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):436-9.
1999: alessandro scalise; Francesco Barchiesi; Maria Anna Viviani; Daniela Arzeni; Aldo Bertani; Giorgio Scalise
Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot.
The Journal of infection 1999;38(3):191-2.
1999: Oscar Cirioni; Andrea Giacometti; D Drenaggi; F Ancarani; Giorgio Scalise
Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts.
European journal of epidemiology 1999;15(4):389-93.
1999: Francesco Barchiesi; Anna M Schimizzi; Annette W Fothergill; Giorgio Scalise; M G Rinaldi
In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(4):302-4.
1999: Francesco Barchiesi; L Falconi Di Francesco; Daniela Arzeni; F Caselli; D Gallo; Giorgio Scalise
Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(3):184-7.
1999: Francesco Barchiesi; Anna Maria Tortorano; L Falconi Di Francesco; Massimo Cogliati; Giorgio Scalise; Maria Anna Viviani
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
The Journal of antimicrobial chemotherapy 1999;43(2):295-9.
1998: Francesco Barchiesi; Daniela Arzeni; P Compagnucci; L Falconi Di Francesco; Andrea Giacometti; Giorgio Scalise
In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(6):437-40.
1998: Andrea Giacometti; Oscar Cirioni; G Greganti; M Quarta; Giorgio Scalise
In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria.
Antimicrobial agents and chemotherapy 1998;42(12):3320-4.
1998: A Giacometti; O Cirioni; D Drenaggi; P Compagnucci; M Quarta; M Fortuna; Giorgio Scalise
Strongyloides stercoralis infection: unknown transmission or late recrudescence?
The Journal of infection 1998;37(3):306-7.
1998: Oscar Cirioni; Andrea Giacometti; Francesco Barchiesi; Giorgio Scalise
In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1998;42(4):445-51.
1998: Andrea Giacometti; Oscar Cirioni; M Quarta; Anna M Schimizzi; Maria Simona Del Prete; Giorgio Scalise
Unusual clinical presentation of infection due to Flavimonas oryzihabitans.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(9):645-8.
1998: D Drenaggi; Oscar Cirioni; Andrea Giacometti; A Fiorentini; Giorgio Scalise
Cyclosporiasis in a traveler returning from South America.
Journal of travel medicine 1998;5(3):153-5.
1998: Daniela Arzeni; Francesco Barchiesi; P Compagnucci; Andreina Cellini; Oriana Simonetti; Annamaria Offidani; Giorgio Scalise
In vitro activity of terbinafine against clinical isolates of dermatophytes.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(4):235-7.
1998: Oscar Cirioni; Andrea Giacometti; Francesco Barchiesi; Giorgio Scalise
In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1998;42(2):141-5.
1998: Anna Maria Tortorano; Maria Anna Viviani; Francesco Barchiesi; Daniela Arzeni; Anna Lisa Rigoni; Massimo Cogliati; P Compagnucci; Giorgio Scalise
Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.
Journal of clinical microbiology 1998;36(6):1578-83.
1998: Annamaria Offidani; C Simoncini; Daniela Arzeni; Andreina Cellini; Amerio Paolo; Giorgio Scalise
Tinea capitis due to Microsporum gypseum in an adult.
Mycoses 1998;41(5-6):239-41.
1998: Francesco Barchiesi; Daniela Arzeni; M S Del Prete; A Sinicco; L Falconi Di Francesco; Maria Bruna Pasticci; L Lamura; M M Nuzzo; F Burzacchini; S Coppola; F Chiodo; Giorgio Scalise
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
The Journal of antimicrobial chemotherapy 1998;41(5):541-8.
1998: Francesco Barchiesi; L Falconi Di Francesco; P Compagnucci; Daniela Arzeni; Andrea Giacometti; Giorgio Scalise
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
The Journal of antimicrobial chemotherapy 1998;41(1):59-65.
1997: Andrea Giacometti; Oscar Cirioni; M Balducci; D Drenaggi; M Quarta; M De Federicis; P Ruggeri; D Colapinto; G Ripani; Giorgio Scalise
Epidemiologic features of intestinal parasitic infections in Italian mental institutions.
European journal of epidemiology 1997;13(7):825-30.
1997: Oscar Cirioni; Andrea Giacometti; M Quarta; Giorgio Scalise
In-vitro activity of topoisomerase inhibitors against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1997;40(4):583-6.
1997: Francesco Barchiesi; L Falconi Di Francesco; P Compagnucci; Daniela Arzeni; Oscar Cirioni; Giorgio Scalise
Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(8):601-5.
1997: Francesco Barchiesi; L Falconi Di Francesco; Giorgio Scalise
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Antimicrobial agents and chemotherapy 1997;41(8):1812-4.
1997: Daniela Arzeni; Maurizio Del Poeta; Oriana Simonetti; Annamaria Offidani; L Lamura; M Balducci; N Cester; Andrea Giacometti; Giorgio Scalise
Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.
European journal of epidemiology 1997;13(4):447-50.
1997: Andrea Giacometti; Oscar Cirioni; F Burzacchini; M S Del Prete; M Balducci; I al Natour; Giorgio Scalise
Rhodococcus equi infections: antibiotic therapy and relapses.
AIDS (London, England) 1997;11(1):120-1.
1997: Oscar Cirioni; Andrea Giacometti; Giorgio Scalise
In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1997;39(1):45-51.
1996: Andrea Giacometti; Oscar Cirioni; Giorgio Scalise
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.
The Journal of antimicrobial chemotherapy 1996;38(3):399-408.
1996: Oscar Cirioni; Andrea Giacometti; F Burzacchini; M Balducci; Giorgio Scalise
Strongyloides stercoralis first-stage larvae in the lungs of a patient with AIDS: primary localization or a noninvasive form of dissemination?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(4):737.
1995: Andrea Giacometti; Maria Simona Del Prete; Oscar Cirioni; M K Izat; M Balducci; A M Cesarini; Giorgio Scalise
Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa.
Journal of chemotherapy (Florence, Italy) 1995;7 Suppl 4():76-7.
1995: Oscar Cirioni; Andrea Giacometti; M Balducci; F Burzacchini; Giorgio Scalise
In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1995;36(4):740-2.
1995: Oscar Cirioni; Andrea Giacometti; M Balducci; D Drenaggi; Maria Simona Del Prete; Giorgio Scalise
Anticryptosporidial activity of paromomycin.
The Journal of infectious diseases 1995;172(4):1169-70.
1995: Eugenio Mocchegiani; S Veccia; F Ancarani; Giorgio Scalise; N Fabris
Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS.
International journal of immunopharmacology 1995;17(9):719-27.
1995: Francesco Barchiesi; Richard J Hollis; Maurizio Del Poeta; D A McGough; Giorgio Scalise; Michael G Rinaldi; Michael A Pfaller
Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):561-4.
1995: Francesco Barchiesi; Richard J Hollis; D A McGough; Giorgio Scalise; Michael G Rinaldi; Michael A Pfaller
DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(3):634-40.
1995: Patrizia Bagnarelli; Stefano Menzo; A Valenza; S Paolucci; S Petroni; Giorgio Scalise; Riccardo Sampaolesi; aldo manzin; Pietro E Varaldo; Massimo Clementi
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.
Journal of clinical microbiology 1995;33(1):16-23.
1994: Maurizio Del Poeta; Francesco Barchiesi; Daniela Arzeni; G Marinucci; Giorgio Scalise
Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates.
Mycoses 1994;37(11-12):411-6.
1994: Claudio Piersimoni; Stefano Bornigia; G De Sio; Giorgio Scalise
Bacteriostatic and bactericidal activities of paromomycin against Mycobacterium avium complex isolates.
The Journal of antimicrobial chemotherapy 1994;34(3):421-4.
1994: Maurizio Del Poeta; Francesco Barchiesi; V Morbiducci; Daniela Arzeni; G Marinucci; F Ancarani; Giorgio Scalise
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Journal of chemotherapy (Florence, Italy) 1994;6(3):173-6.
1994: Francesco Barchiesi; Maurizio Del Poeta; V Morbiducci; F Ancarani; Giorgio Scalise
Effect of pentamidine on the growth of Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 1994;33(6):1229-32.
1994: Andrea Giacometti; F M Siquini; Oscar Cirioni; S Petroni; Giorgio Scalise
Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(4):315-8.
1994: Patrizia Bagnarelli; A Valenza; Stefano Menzo; aldo manzin; Giorgio Scalise; Pietro E Varaldo; Massimo Clementi
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo.
Journal of virology 1994;68(4):2495-502.
1993: Alessandra Arzese; C Pipan; Claudio Piersimoni; Giorgio Scalise; V Morbiducci; GA Botta
Characterization of mesophilic Aeromonas from clinical specimens by computerized analysis of SDS-PAGE protein profiles and by enzymatic activity.
The new microbiologica 1993;16(4):333-42.
1993: Francesco Barchiesi; Maurizio Del Poeta; V Morbiducci; F Ancarani; Giorgio Scalise
Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans.
Mycopathologia 1993;124(1):19-25.
1993: Francesco Barchiesi; V Morbiducci; F Ancarani; Giorgio Scalise
Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients.
European journal of epidemiology 1993;9(4):455-6.
1993: Francesco Barchiesi; V Morbiducci; F Ancarani; Daniela Arzeni; Giorgio Scalise
Trichosporon beigelii fungaemia in an AIDS patient.
AIDS (London, England) 1993;7(1):139-40.
1992: Patrizia Bagnarelli; Stefano Menzo; A Valenza; aldo manzin; M Giacca; F Ancarani; Giorgio Scalise; Pietro E Varaldo; Massimo Clementi
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.
Journal of virology 1992;66(12):7328-35.
1992: Claudio Piersimoni; V Morbiducci; Stefano Bornigia; G De Sio; Giorgio Scalise
In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
The American review of respiratory disease 1992;146(6):1445-7.
1992: Claudio Piersimoni; V Morbiducci; G De Sio; Giorgio Scalise
Comparative evaluation of the MB-Check system for recovery of mycobacteria from clinical specimens.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(12):1174-7.
1992: Francesco Barchiesi; Andrea Giacometti; Daniela Arzeni; P Branchesi; G Crescenzi; F Ancarani; Giorgio Scalise
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Journal of chemotherapy (Florence, Italy) 1992;4(6):381-6.
1992: Eugenio Mocchegiani; Giorgio Scalise; S Veccia; N Fabris
Zinc-dependent thymic hormone failure in AIDS.
Annals of the New York Academy of Sciences 1992;650():94-8.
1991: Claudio Piersimoni; L Felici; P Giorgi; V Morbiducci; Giorgio Scalise
Mixed mycobacterial infection of cervical lymph nodes.
The Pediatric infectious disease journal 1991;10(7):544-5.
1991: D Drenaggi; E Petrelli; G Cagnoni; F Ancarani; M Agostinelli; Andrea Giacometti; Giorgio Scalise
Therapy with immunoglobulin of the HIV infection related idiopathic thrombocytopenia.
Allergologia et immunopathologia 1991;19(4):157-9.
1991: Daniela Arzeni; Francesco Barchiesi; F Ancarani; Giorgio Scalise
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
Journal of chemotherapy (Florence, Italy) 1991;3(3):139-42.
1991: Claudio Piersimoni; V Morbiducci; Giorgio Scalise
Non-O1 Vibrio cholerae gastroenteritis and bacteraemia.
Lancet 1991;337(8744):791-2.
1991: Andrea Giacometti; A Fiorentini; M R Mazzoccanti; S Mengoni; S Petroni; Giorgio Scalise
Epidemiological surveillance of staphylococcal resistance.
Journal of chemotherapy (Florence, Italy) 1991;3 Suppl 1():163-5.
1991: Andrea Giacometti; P Branchesi; G Corbelli; A Fiorentini; S Petroni; Giorgio Scalise
[Routine isolation of mutants resistant to beta-lactams among gram-negative microorganisms].
Giornale italiano di chemioterapia 1991;38(1-3):149-50.
1990: Andrea Giacometti; P Pongetti; E Petrelli; Giorgio Scalise
Imipenem/cilastatin treatment of acute infections in AIDS/ARC patients.
Journal of chemotherapy (Florence, Italy) 1990;2(4):247-51.
1990: Claudio Piersimoni; V Morbiducci; G De Sio; Giorgio Scalise
Rapid presumptive phenospecies identification of mesophilic aeromonads by testing for suicidal activity.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(8):608-10.